Confidential
Execution Version
15.2.9 Termination for Competitor Change of Control. Licensee shall notify Bioeq in writing within [***]
([***]) days after entry by Licensee into a definitive agreement which would result in a Competitor Change of Control. During the
period between when Licensee enters into a definitive agreement which would result in a Competitor Change of Control and when
such definitive agreement is consummated, Licensee shall have the right to divest all such Competitive Products which would be
acquired upon the consummation of the transaction giving rise to such Competitor Change of Control. Upon the consummation of
such definitive agreement, if Licensee has not then divested all such Competitive Products such that a Competitor Change of Control
has occurred, Bioeq may, upon sending written notice to Licensee within sixty (60) days thereafter, terminate this Agreement.
15.2.10 Effect of Termination of the [***] Agreement. Without limiting Bioeq’s obligations under Article 10, in
the event that the [***] Agreement is terminated by [***], Bioeq will notify Licensee thereof immediately, and Licensee may
terminate this Agreement upon written notice to Bioeq.
15.2.11 Written Notice. Any termination shall only be valid if made in writing and delivered to the other Party
under the address set forth in Section 16.1.
15.3 Effect of Termination. In case of any termination or expiration of this Agreement, all rights and obligations of
the Parties shall cease immediately, unless otherwise indicated in this Section below or elsewhere in this Agreement:
15.3.1 Sale of Inventory. Licensee shall be permitted, at Bioeq’s choice (if this Agreement is terminated by Bioeq
pursuant to Sections 15.2.1, 15.2.2, 15.2.3, 15.2.4, 15.2.8 or 15.2.9, or by Licensee pursuant to Section 15.2.5) or at Licensee’s choice
(if this Agreement is terminated by Licensee pursuant to Sections 15.2.1, 15.2.6, 15.2.7 or 15.2.8), to cither (a) continue selling its and
its Affiliates’ inventory of Licensed Products existing on the termination effective date in accordance with this Agreement for a
maximum period of [***] ([***]) days (in which case all terms and conditions of this Agreement, including Licensee’s obligation to
report and pay royalties, shall continue to apply to such continued sale) or (b) sell such inventory to Bioeq at the supply price paid by
Licensee to Bioeq for such inventory in accordance with the Manufacturing and Supply Agreement.
15.3.2 Transfer of Biologics License Application Approvals. Licensee shall, within [***] ([***]) days of the
effective date of termination of the Agreement at the latest (and at no cost to Bioeq if this Agreement is terminated by Bioeq
pursuant to Sections 15.2.1, 15.2.2, 15.2.3, 15.2.4, 15.2.8 or 15.2.9, or by Licensee pursuant to Section 15.2.5, or at Bioeq’s cost and
expense if this Agreement is terminated by Licensee pursuant to Sections 15.2.1, 15.2.6, 15.2.7 or 15.2.8, as applicable) transfer and
assign to Bioeq or its designee all of Licensee’s right, title and interest in and to any and all Biologics License Applications and
Biologics License Application Approvals controlled by Licensee for the Licensed Products in the Field in the Territory as of the
effective date of such termination, including any and all documentation pertaining to such filings and Biologics License Application
Approvals (provided that the physical or electronic transfer of files and documentation in connection with such transfer and
assignment of rights may occur after such [***] ([***]) day period without being deemed a breach of this Section 15.3.2 by
Licensee). In addition, upon Bioeq’s request, Licensee shall notify the competent Regulatory Authority of such transfer, supply Bioeq
with all documents already prepared by Licensee or its Affiliates for the filing of applications in relation to the Licensed Products with
any Regulatory Authority and/or apply for the closing of any such application. Notwithstanding any other rights Bioeq may have under
this Agreement or Applicable Law; if Licensee does not transfer and assign to Bioeq or its designee its rights in any Biologics License
Applications and Biologics License Application Approvals controlled by Licensee for the Licensed Products in the Field in the
Territory within the above [***] ([***]) day time period (provided that the physical or electronic transfer of files and documentation in
connection with such transfer and assignment
Source: COHERUS BIOSCIENCES, INC., 10-K, 2/27/2020